UTI Healthcare Fund - Direct Plan - Growth Option

NAV: as on:
MIn SIP Amount: 500
Rating: Not Rated
Fund Size: 1088.6303
SIP Amount
Frequency
SIP Start Date
Holdings
Name Sector Instrument Type Assets(%)
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 11.61
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 11.61
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 11.61
Cipla Ltd Pharmaceuticals -- 6.66
Cipla Ltd Pharmaceuticals -- 6.66
Cipla Ltd Pharmaceuticals -- 6.66
Ajanta Pharma Ltd Pharmaceuticals -- 5.82
Ajanta Pharma Ltd Pharmaceuticals -- 5.82
Ajanta Pharma Ltd Pharmaceuticals -- 5.82
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 5.4
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 5.4
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 5.4
Apollo Hospitals Enterprises Ltd Health Care -- 3.94
Apollo Hospitals Enterprises Ltd Health Care -- 3.94
Apollo Hospitals Enterprises Ltd Health Care -- 3.94
Procter & Gamble Health Ltd Pharmaceuticals -- 3.57
Procter & Gamble Health Ltd Pharmaceuticals -- 3.57
Procter & Gamble Health Ltd Pharmaceuticals -- 3.57
Glenmark Pharmaceuticals Ltd Pharmaceuticals -- 3.38
Glenmark Pharmaceuticals Ltd Pharmaceuticals -- 3.38
Glenmark Pharmaceuticals Ltd Pharmaceuticals -- 3.38
Aurobindo Pharma Ltd Pharmaceuticals -- 3.36
Aurobindo Pharma Ltd Pharmaceuticals -- 3.36
Aurobindo Pharma Ltd Pharmaceuticals -- 3.36
Krishna Institute Of Medical Sciences Ltd Health Care -- 3.31
Krishna Institute Of Medical Sciences Ltd Health Care -- 3.31
Krishna Institute Of Medical Sciences Ltd Health Care -- 3.31
Gland Pharma Ltd Pharmaceuticals -- 3.23
Gland Pharma Ltd Pharmaceuticals -- 3.23
Gland Pharma Ltd Pharmaceuticals -- 3.23
Eris Lifesciences Ltd Pharmaceuticals -- 3.1
Eris Lifesciences Ltd Pharmaceuticals -- 3.1
Eris Lifesciences Ltd Pharmaceuticals -- 3.1
Divi'S Laboratories Ltd Pharmaceuticals -- 3.02
Divi'S Laboratories Ltd Pharmaceuticals -- 3.02
Divi'S Laboratories Ltd Pharmaceuticals -- 3.02
Suven Pharmaceuticals Ltd Pharmaceuticals -- 2.96
Suven Pharmaceuticals Ltd Pharmaceuticals -- 2.96
Suven Pharmaceuticals Ltd Pharmaceuticals -- 2.96
Fortis Healthcare Ltd Health Care -- 2.93
Fortis Healthcare Ltd Health Care -- 2.93
Fortis Healthcare Ltd Health Care -- 2.93
Zydus Lifesciences Ltd Pharmaceuticals -- 2.81
Zydus Lifesciences Ltd Pharmaceuticals -- 2.81
Zydus Lifesciences Ltd Pharmaceuticals -- 2.81
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 2.62
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 2.62
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 2.62
Metropolis Healthcare Ltd Health Care -- 2.22
Metropolis Healthcare Ltd Health Care -- 2.22
Metropolis Healthcare Ltd Health Care -- 2.22
Alkem Laboratories Ltd Pharmaceuticals -- 2.07
Alkem Laboratories Ltd Pharmaceuticals -- 2.07
Alkem Laboratories Ltd Pharmaceuticals -- 2.07
Pfizer Ltd Pharmaceuticals -- 1.97
Pfizer Ltd Pharmaceuticals -- 1.97
Pfizer Ltd Pharmaceuticals -- 1.97
Caplin Point Laboratories Ltd Pharmaceuticals -- 1.74
Caplin Point Laboratories Ltd Pharmaceuticals -- 1.74
Caplin Point Laboratories Ltd Pharmaceuticals -- 1.74
Jupiter Life Line Hospitals Ltd Health Care -- 1.65
Jupiter Life Line Hospitals Ltd Health Care -- 1.65
Jupiter Life Line Hospitals Ltd Health Care -- 1.65
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 1.64
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 1.64
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 1.64
Aster Dm Healthcare Ltd Health Care -- 1.56
Aster Dm Healthcare Ltd Health Care -- 1.56
Aster Dm Healthcare Ltd Health Care -- 1.56
Marksans Pharma Ltd Pharmaceuticals -- 1.55
Marksans Pharma Ltd Pharmaceuticals -- 1.55
Marksans Pharma Ltd Pharmaceuticals -- 1.55
Ipca Laboratories Ltd Pharmaceuticals -- 1.44
Ipca Laboratories Ltd Pharmaceuticals -- 1.44
Ipca Laboratories Ltd Pharmaceuticals -- 1.44
Star Health And Allied Insurance Company Ltd Insurance -- 1.37
Star Health And Allied Insurance Company Ltd Insurance -- 1.37
Star Health And Allied Insurance Company Ltd Insurance -- 1.37
Windlas Biotech Ltd Pharmaceuticals -- 1.34
Syngene International Ltd Health Care -- 1.34
Syngene International Ltd Health Care -- 1.34
Windlas Biotech Ltd Pharmaceuticals -- 1.34
Syngene International Ltd Health Care -- 1.34
Windlas Biotech Ltd Pharmaceuticals -- 1.34
Max Healthcare Institute Ltd Health Care -- 1.33
Max Healthcare Institute Ltd Health Care -- 1.33
Max Healthcare Institute Ltd Health Care -- 1.33
Alembic Pharmaceuticals Ltd Pharmaceuticals -- 1.31
Alembic Pharmaceuticals Ltd Pharmaceuticals -- 1.31
Alembic Pharmaceuticals Ltd Pharmaceuticals -- 1.31
Concord Biotech Ltd Pharmaceuticals -- 1.21
Concord Biotech Ltd Pharmaceuticals -- 1.21
Concord Biotech Ltd Pharmaceuticals -- 1.21
Orchid Pharma Ltd Pharmaceuticals -- 1.14
Orchid Pharma Ltd Pharmaceuticals -- 1.14
Orchid Pharma Ltd Pharmaceuticals -- 1.14
Sequent Scientific Ltd Pharmaceuticals -- 1.12
Sequent Scientific Ltd Pharmaceuticals -- 1.12
Sequent Scientific Ltd Pharmaceuticals -- 1.12
Ami Organics Ltd Pharmaceuticals -- 1.11
Ami Organics Ltd Pharmaceuticals -- 1.11
Ami Organics Ltd Pharmaceuticals -- 1.11
Vijaya Diagnostic Centre Ltd Health Care -- 1.09
Vijaya Diagnostic Centre Ltd Health Care -- 1.09
Vijaya Diagnostic Centre Ltd Health Care -- 1.09
Cash/Bank/Net Current Assets/(Liabilities) Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.03
Cash/Bank/Net Current Assets/(Liabilities) Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.03
Cash/Bank/Net Current Assets/(Liabilities) Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.03
Poly Medicure Ltd Health Care -- 0.97
Poly Medicure Ltd Health Care -- 0.97
Poly Medicure Ltd Health Care -- 0.97
Indegene Ltd Healthcare Services -- 0.95
Indegene Ltd Healthcare Services -- 0.95
Indegene Ltd Healthcare Services -- 0.95
Rainbow Children'S Medicare Ltd Health Care -- 0.67
Rainbow Children'S Medicare Ltd Health Care -- 0.67
Rainbow Children'S Medicare Ltd Health Care -- 0.67
Indoco Remedies Ltd Pharmaceuticals -- 0.34
Indoco Remedies Ltd Pharmaceuticals -- 0.34
Indoco Remedies Ltd Pharmaceuticals -- 0.34
364 DAYS T - BILL- 06/02/2025 Govt-Sec -- 0.12
364 DAYS T - BILL- 06/02/2025 Govt-Sec -- 0.12
364 DAYS T - BILL- 06/02/2025 Govt-Sec -- 0.12
CLEARING CORPORATION OF INDIA LTD. STD - MARGIN Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.01
CLEARING CORPORATION OF INDIA LTD. STD - MARGIN Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.01
CLEARING CORPORATION OF INDIA LTD. STD - MARGIN Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.01
Holding analysis
Asset Class Percentage
Equity 98.8503
Debt 0
Cash
Equity sector allocation
Pharmaceuticals
Health Care
Insurance
Cash/Deposits/Margins/Treps/Repo/Swaps
Healthcare Services
Govt-Sec
226.56
63.03
4.11
3.12
2.85
0.36
Sector Holding Percentage
Pharmaceuticals 226.56
Health Care 63.03
Insurance 4.11
Cash/Deposits/Margins/Treps/Repo/Swaps 3.12
Healthcare Services 2.85
Govt-Sec 0.36
Advanced Ratios
Standard Dev. 12.0038
P/E Ratio 46.8494
Sharpe -0.9317
Alpha 1.724
Beta 0.877
Sortino 0.2321
Minimum Investment Amounts
Minimum for 1st Investment 5000
Minimum for SIP 500
Returns and rankings
Category : Equity
Annualised returns
1Y 3Y 5Y
Fund returns 57.41 19.86 30.57
Category average -9.1 23.3 12.4
Rank with in category
Expense ratio:1.3

Inclusive of GST

Exit load

1% on or before 30D, Nil after 30D

Stamp duty

0.005% (from July 1st, 2020)

Tax implication

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Fund house & investment objective
Rank (total assets) ---
Total AUM ₹3,41,353.47Cr
Date of Incorporation ---

Investment Objective

The Primary Objective Of The Scheme Is To Generate Long Term Capital Appreciation By Investing Predominantly In Equity And Equity Related Securities Of Companies/Institutions Engaged In The Healthcare Services Sector. However, There Can Be No Assurance Or Guarantee That The Investment Objective Of The Scheme Would Be Achieved.

Fund benchmark S&P BSE Health Care
Fund house contact details
Address: UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East)
Mumbai - 400 051
Phone:--------
Launch Date:--------
Website: www.utimf.com
UTI Asset Management Company Private Limited
Custodian:Deutsche Bank
Registrar & Transfer Agent:Karvy
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
Compare funds
Funds Comparison
Fund management
Kamal Gada
Jan 2013 - Present
Education
--------------
Experience
--------------
Fund manager Also manages these schemes